Overview

ESP in Breast Surgery Due to Cancer

Status:
Completed
Trial end date:
2021-08-17
Target enrollment:
Participant gender:
Summary
Patients scheduled for breast surgery due to cancer. Each patient will be treated with intravenous (i.v.) oxycodone - patient-controlled analgesia (PCA). Patients will be allocated to one of three groups: erector spinae plane (ESP) block, sham block, controlled group.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Lublin
Treatments:
Acetaminophen
Oxycodone